SAMANTHA YAKUBOV: Open Payments
NPI 1649724576 · MANHASSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 44 payments from 14 companies in 2025. Trend: 2023 $1,375 · 2024 $1,040 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 20 | $295 |
| Antares Pharma, Inc. | 5 | $99 |
| UROGEN PHARMA, INC. | 3 | $83 |
| ABBVIE INC. | 4 | $70 |
| Janssen Biotech, Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $30 |
| Ferring Pharmaceuticals Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: ORGOVYX, GEMTESA, XYOSTED, BOTOX, ERLEADA, Nubeqa, PYLARIFY, JELMYTO.
Industry payments across NY — which companies pay providers there.
